References
Bishop MR, Cairo MS, Coccia PF. Tumor lysis syndrome. In: Abeloff MD, editor. Clinical oncology. 3rd ed. Orlando, Fl: Churchill Livingstone; 2004. p. 50.
Economopoulos P, Christopoulos C. Glucagonoma. Ann Gastroenterol. 2001;14(2):99–108.
Milan S, Yeo C. Neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2012;24(1):46–55.
Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci. 2001;321(5):306–20.
Gaiser CA, Dhawan N. Paradoxical presentation of glucagonoma with delayed onset of necrolytic migratory Erythema. Am J Med. 2015;128(2):e1–2.
Keizer B, Van Aken M, Feelders R, et al. Hormonal crises following receptor radioneclide therapy with radiolabeled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate. Eur J Nucl Med Mol Imaging. 2008;35:749–55.
Davi B, Bodei L, Bartolomei M, et al. Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). J Endocrinol Investig. 2006;29(6):563–7.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gaiser, C.A., Dhawan, N. Proposed Radiation Induced Hormone Crisis in a Patient with Glucagonoma. J Gastrointest Canc 47, 466–467 (2016). https://doi.org/10.1007/s12029-015-9771-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-015-9771-7